P3 Health Partners Stock Buy Hold or Sell Recommendation
| PIII Stock | USD 0.17 0.01 5.56% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding P3 Health Partners is 'Strong Sell'. The recommendation algorithm takes into account all of P3 Health's available fundamental, technical, and predictive indicators you will find on this site.
Check out P3 Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as PIII and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
PIII |
Execute P3 Health Buy or Sell Advice
The PIII recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on P3 Health Partners. Macroaxis does not own or have any residual interests in P3 Health Partners or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute P3 Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
P3 Health Trading Alerts and Improvement Suggestions
| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners currently holds 121.94 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 B. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (40.2 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a frail financial position based on the latest SEC disclosures | |
| Roughly 62.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27 |
P3 Health Returns Distribution Density
The distribution of P3 Health's historical returns is an attempt to chart the uncertainty of P3 Health's future price movements. The chart of the probability distribution of P3 Health daily returns describes the distribution of returns around its average expected value. We use P3 Health Partners price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of P3 Health returns is essential to provide solid investment advice for P3 Health.
| Mean Return | -0.32 | Value At Risk | -5.56 | Potential Upside | 9.52 | Standard Deviation | 5.48 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of P3 Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PIII Stock Institutional Investors
| Shares | Cresset Asset Management, Llc | 2024-12-31 | 150 K | Warberg Asset Management Llc | 2024-12-31 | 145.3 K | Blair William & Co | 2024-12-31 | 125.8 K | Moneta Group Investment Advisors Inc | 2024-12-31 | 112.8 K | State Street Corp | 2024-12-31 | 101.4 K | Northern Trust Corp | 2024-12-31 | 100 K | Welch Capital Partners Llc | 2024-12-31 | 90 K | Prudential Investment Management Inc | 2024-09-30 | 88 K | Hrt Financial Llc | 2024-12-31 | 71.3 K | Alyeska Investment Group, L.p. | 2024-12-31 | 11.9 M | Vanguard Group Inc | 2024-12-31 | 1.8 M |
P3 Health Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (3.9M) | (3.2M) | (7.7M) | (2.0M) | (2.3M) | (2.4M) | |
| Change In Cash | 7.0M | 100.9M | (122.4K) | 22.5M | 25.8M | 29.5M | |
| Free Cash Flow | (29.7M) | (27.5M) | (128.3K) | (77.9M) | (70.1M) | (66.6M) | |
| Depreciation | 795.2K | 8.7M | 87.3K | 86.7M | 99.7M | 104.7M | |
| Other Non Cash Items | (1.6M) | 7.0M | 1.3M | 15.9M | 18.3M | 19.3M | |
| Capital Expenditures | 2.9M | 3.4M | 2.2K | 1.8M | 1.6M | 1.7M | |
| Net Income | (45.4M) | (156.5M) | (1.6M) | (57.8M) | (52.0M) | (54.6M) |
P3 Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to P3 Health or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that P3 Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a PIII stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 5.62 | |
Ir | Information ratio | -0.04 |
P3 Health Volatility Alert
P3 Health Partners exhibits very low volatility with skewness of 1.43 and kurtosis of 3.1. P3 Health Partners is a potential penny stock. Although P3 Health may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in P3 Health Partners. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on PIII instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.P3 Health Fundamentals Vs Peers
Comparing P3 Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze P3 Health's direct or indirect competition across all of the common fundamentals between P3 Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as P3 Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of P3 Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing P3 Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare P3 Health to competition |
| Fundamentals | P3 Health | Peer Average |
| Return On Equity | -0.65 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Profit Margin | (0.07) % | (1.27) % |
| Operating Margin | (0.31) % | (5.51) % |
| Current Valuation | 109.31 M | 16.62 B |
| Shares Outstanding | 163.12 M | 571.82 M |
| Shares Owned By Insiders | 62.07 % | 10.09 % |
| Shares Owned By Institutions | 13.04 % | 39.21 % |
| Number Of Shares Shorted | 1.91 M | 4.71 M |
| Price To Book | 0.23 X | 9.51 X |
| Price To Sales | 0.07 X | 11.42 X |
| Revenue | 1.27 B | 9.43 B |
| Gross Profit | (40.2 M) | 27.38 B |
| EBITDA | (81.07 M) | 3.9 B |
| Net Income | (57.77 M) | 570.98 M |
| Cash And Equivalents | 63.15 M | 2.7 B |
| Cash Per Share | 1.52 X | 5.01 X |
| Total Debt | 121.94 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 0.75 X | 2.16 X |
| Book Value Per Share | 0.74 X | 1.93 K |
| Cash Flow From Operations | (76.03 M) | 971.22 M |
| Short Ratio | 1.40 X | 4.00 X |
| Earnings Per Share | (0.86) X | 3.12 X |
| Target Price | 0.63 | |
| Number Of Employees | 400 | 18.84 K |
| Beta | 0.93 | -0.15 |
| Market Capitalization | 97.08 M | 19.03 B |
| Total Asset | 860.97 M | 29.47 B |
| Retained Earnings | (367.34 M) | 9.33 B |
| Working Capital | (133.35 M) | 1.48 B |
| Net Asset | 860.97 M |
Note: Acquisition by Park Jeffrey G of 482640 shares of P3 Health at 0.5461 subject to Rule 16b-3 [view details]
P3 Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PIII . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About P3 Health Buy or Sell Advice
When is the right time to buy or sell P3 Health Partners? Buying financial instruments such as PIII Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having P3 Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corporate Bonds Funds Thematic Idea Now
Corporate Bonds Funds
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out P3 Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share | Quarterly Revenue Growth 0.256 | Return On Assets | Return On Equity |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.